New Study Finds Magnesium Better than Antidepressants
Depression is one of the most widely diagnosed of all conditions of our time, with more than 3 million cases in the U.S. every year, and 350 million believed affected worldwide (http://www.who.int/mediacentre/factsheets/fs369/en/). Conventional medicine considers antidepressant drugs first-line treatments, including the newly approved injected postpartum drug costing $34,000 a treatment, for $16 Billion in global sales by 2023 (comprised of a proprietary form of brexanalone [a synthetic hormone] to be sold under the brand name Zulresso by Sage Therapeutics. Just think about that!